USAR is the single-cleanest equity expression of a real bottleneck: NdFeB magnets are choke-point components for defense, EVs, and AI-power infrastructure, and China controls roughly 90% of the supply chain. The company has $1.75B in cash, the Stillwater plant commissioned and producing commercial magnets, an integrated mine-to-magnet platform after Serra Verde and Carester, and $1.6B of US government funding in final documentation. Wall Street is firmly bullish (consensus Strong Buy, target ~$34-37, ~25-35% upside). The risks are real but knowable: a multi-year ramp, dilution funding the build, and a stock that has already moved triple-digits. The position is to own this for the structural story, not chase the next 30% move.
Almost every high-performance permanent magnet on earth is NdFeB (neodymium-iron-boron), and these magnets sit inside almost everything the modern economy now treats as strategic: precision-guided weapons, EV traction motors, wind turbines, robotics, the cooling systems and motors threaded through every AI data center. China processes roughly 90% of the world's rare earths and manufactures the overwhelming majority of finished magnets. That is the bottleneck. It has been a known problem for two decades and a politically actionable one for the last two years, after Beijing imposed export licensing on rare-earth processing technologies and magnet manufacturing equipment in October 2025.
USA Rare Earth is the most complete Western answer to that bottleneck on the public market. After Q1 2026 it is, by its own description, "the only fully-integrated mine-to-magnet platform outside China," with: a heavy-rare-earth deposit in Texas (Round Top, now 100% owned after the TMRC consolidation), a metal-making and alloy facility in the UK (LCM, generating early revenue), a sintered NdFeB magnet plant in Oklahoma (Stillwater, Phase 1a commissioned March 2026 and producing commercial magnets), and after the pending Serra Verde acquisition (Brazil, ~$2.8B), a second feedstock source spanning three continents. Add the Carester investment for heavy-rare-earth processing IP and the picture is a vertically integrated platform under one ticker.
The catalyst is dated and contractual: the $1.6B Department of Commerce funding agreement is in final documentation, on top of a $14.2M Texas grant already received and a $1.5B PIPE that closed in January. The buyer-of-last-resort is the US government and the demand wall is legislated; a ban on Chinese-origin NdFeB magnets in US defense systems takes effect January 1, 2027. That is not theme-investing; that is a written deadline meeting a written check.
This is the differentiator in one picture: every box is owned or being acquired by USAR. China controls roughly 90% of the rare-earth supply chain by integrating exactly these stages; USAR is the only public company replicating that full chain (mine, feedstock, metal-making, sintered NdFeB magnets) outside China. The value concentrates at the right-hand box: magnets are where a tonne of oxide becomes a defense-grade, high-margin component, and where the 2027 demand wall pays out.
The mine matters, the metal-making matters, but the value lives at one address: the Stillwater facility in Oklahoma. Magnets are where a tonne of rare-earth oxide becomes a high-margin, defense-grade component, and where the 2027 demand wall pays out. Everything else USAR is doing is supply security around that one asset.
Two pieces of leverage matter. First, operating leverage: this is a fixed-cost build-out. Once Stillwater is qualified and shipping, incremental magnet revenue drops to gross profit at a high rate; the entire investment case is the bend in the cost curve that arrives sometime in 2026-2027. Second, policy leverage: the 2027 magnet ban means qualified defense primes must source domestic. There is essentially no domestic competition at scale today, which is the moat. MP Materials is the only other US name with credible magnet aspirations (Independence plant, magnet sales targeted 2H 2026) and remains primarily a concentrate producer; everyone else is years behind.
The thesis is dated and contractual, not thematic: a written deadline (the 2027 ban) meeting a written check ($1.6B Commerce funding in final documentation). That is what separates USAR from a generic rare-earth story.
Honesty first: the income statement is barely a guide. Q1 revenue of $5.7M (which beat consensus of $4.2M) sits against a $37M operating loss and a $67M net loss; cash burn from operations was $18.6M. These are commissioning numbers, not earnings numbers, and pretending otherwise misses the point. What matters is whether the balance sheet funds the ramp to revenue, and on that score it is unusually strong: $1.75B cash, no debt, and $1.6B more of government funding in final documentation. That is enough to fund Stillwater Phases 1a/1b, the LCM scale-up, and the Serra Verde integration without an immediate financing gun.
| $M | Q1'25 | Q1'26 ● | FY26E | FY27E |
|---|---|---|---|---|
| Revenue | ~2 | 5.7 | ~40 | ~180 |
| Operating loss | -8.7 | -36.7 | ~-150 | ~-120 |
| Cash | ~0.3B | 1.75B | ~1.4B | ~1.1B |
| Magnet run-rate (MTPA) | 0 | commissioning | 600 | 1,200+ |
Q1'26 figures from the company's 13 May 2026 release and Q1 transcript. Forward columns illustrative build pending, engine will compute. A reverse DCF off trailing FCF is not meaningful here because FCF is negative by design; the right valuation lens for a pre-revenue ramp is capacity- and milestone-based.
Stillwater magnet capacity ramp (MTPA = metric tonnes per annum). The fair-value method below is built on the 2028 run-rate, because trailing financials understate a pre-revenue ramp by design.
Method: build a 2028 run-rate revenue case (~$700-900M from Stillwater at full 1,200+ MTPA plus LCM at 3,000 MTPA, at defense-grade NdFeB pricing) at a 30-35% gross margin and a peer-comp EV/sales multiple of 6-9× appropriate for a strategic-supply Western producer. Discount back at 12-15% for execution risk; net of cash and assumed dilution, fair value lands ~$32-38 today. Cross-check: the analyst consensus (~$34-37) sits in the same band, and Cantor Fitzgerald raised to $35 OW in May. On fundamentals, USAR screens fairly-to-modestly undervalued, with the upside contingent on Stillwater hitting its 2H-2026 customer-delivery milestones. Miss those and the multiple compresses fast.
Unlike Nokia, where the marquee bulls and the blended consensus disagree, USAR has near-unanimous Street support. The disagreement is purely on magnitude:
The 25 institutional buyers and zero institutional sellers over the last twelve months are the cleanest single read on positioning. Alyeska holds ~9% (the largest external position), with Geode, Vanguard, Schwab, and BofA all adding. The put/call ratio of 0.41 leans bullish. On competition, MP Materials is the only credible US magnet competitor and is targeting first magnet sales in 2H 2026 as well; the rest of the field (Critical Metals, Energy Fuels, NioCorp) is years behind on the magnet end of the chain. The honest framing: in a category Wall Street is trying to underwrite, USAR is the most complete vehicle, and the institutional read reflects that.
On the magnet end of the chain (where the value and the 2027 demand wall sit), MP Materials is the only credible US competitor and is targeting first magnet sales in 2H 2026 as well. Everyone else is upstream-only and years behind.
Three things. (1) Execution, the live risk. Magnet manufacturing at commercial yield is genuinely hard, and USAR has never run a plant at full commercial scale. A delayed customer qualification, a missed Q4 2026 600 MTPA target, or a yield problem in 2027 each derate the multiple. (2) Dilution, the structural risk. The build is being funded with equity (the $1.5B PIPE, Serra Verde shares); a winning thesis can still dilute per-share value if the burn is heavier than planned or if the $1.6B Commerce funding slips. (3) Policy reversal, the tail risk. The thesis rests on the legislated 2027 magnet ban; an administration that softens or delays defense-magnet sourcing rules takes the floor out. None of these breaks the long-term story; they break the price.
Prototype Skyway Coverage brief · facts current to 27 May 2026 (Q1'26 results, post-Q1 strategic transactions, analyst actions, institutional flows all sourced). Forward estimates and fair-value derivation illustrative pending the quant engine. Not investment advice. The brain advises, the trader decides.